EUVIMEDEUVIMED entdecken
Open Access

Retinoid X receptor alpha overexpression protects retinal ganglion cells and modulates inflammatory response in experimental glaucoma

Nitin Chitranshi, Devaraj Basavarajappa, Viswanthram Palanivel, Gabriella E Parrilla, Veer Gupta, Joao A Paulo, Akanksha Salkar, Mehdi Mirzaei, Maya Koronyo-Hamaoui, Wojciech Krezel, Stuart L Graham, Vivek K Gupta

Molecular Therapy · 2025

DOI: 10.1016/j.ymthe.2025.08.034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2025. Verfasst von Nitin Chitranshi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Macquarie Medical School, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW 2109, Australia; School of Science and Technolog…. Hauptthemen laut MEDLINE: Retinal Ganglion Cells, Glaucoma, Retinoid X Receptor alpha, Inflammation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, Ophthalmic Research Institute of Australia, Perpetual.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glaucoma is characterized by the progressive loss of retinal ganglion cells (RGCs) and optic nerve axons, and its risk increases with age. Retinal neuroinflammation and epigenetic changes have been suggested to be key contributors to glaucoma neuropathology. Recent research suggests that activating the retinoid X receptor (RXR) in the retina plays a critical role in modulating various cellular functions, showcasing beneficial effects in animal models of glaucoma. Yet, the neuroprotective mechanisms activated in response to RXR modulation in glaucoma remain unclear. This study investigated the impact of RXR alpha (RXRα) modulation on retinal neurons in vivo under both normal and glaucoma conditions using adeno-associated virus (AAV) gene therapy. RXRα knockdown in RGCs promoted histone deacetylation, pro-inflammatory, and apoptotic changes, along with inducing functional and structural deficits in the inner retina. In contrast, overexpression of RXRα in RGCs protected these cells and preserved inner retinal function in glaucoma through the activation of PI3K/Akt/Gsk3β signaling. This study identified the RXRα-mediated epigenetic and inflammatory regulatory mechanisms in RGCs and established that specifically targeting RXRα in RGCs imparts functional and cellular protection to the retina in glaucoma, with potential implications in other neurodegenerative disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal Ganglion CellsGlaucomaRetinoid X Receptor alphaInflammationAnimalsDisease Models, AnimalMiceDependovirusSignal TransductionGenetic TherapyApoptosisHumans

Stichwörter der Autor:innen

adeno-associated virusapoptosisgene therapyglaucomaneurodegenerationretinal ganglion cellsretinoid X receptor

Substanzen

Retinoid X Receptor alpha

Autor:innen und Institutionen

  • Macquarie Medical School, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW 2109, Australia; School of Science and Technology, The University of New England, Armidale, NSW 2350, Australia. Elect…
  • Macquarie Medical School, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW 2109, Australia.
  • School of Medicine, Deakin University, Melbourne, VIC 3216, Australia.
  • Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Department of Neurosurgery, Maxine Dunitz Neurosurgical Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
  • Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Inserm U1258, CNRS UMR 7104, Université de Strasbourg, Illkirch, France.

Förderung

  • NIA NIH HHS
  • Ophthalmic Research Institute of Australia
  • Perpetual
  • National Health and Medical Research Council

Zitieren

APA

Chitranshi, N., Basavarajappa, D., Palanivel, V., Parrilla, G. E., Gupta, V., Paulo, J. A., Salkar, A., Mirzaei, M., Koronyo-Hamaoui, M., Krezel, W., Graham, S. L., & Gupta, V. K. (2025). Retinoid X receptor alpha overexpression protects retinal ganglion cells and modulates inflammatory response in experimental glaucoma. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2025.08.034

Vancouver

Chitranshi N, Basavarajappa D, Palanivel V, Parrilla GE, Gupta V, Paulo JA, et al. Retinoid X receptor alpha overexpression protects retinal ganglion cells and modulates inflammatory response in experimental glaucoma. Molecular Therapy. 2025. doi:10.1016/j.ymthe.2025.08.034

BibTeX
@article{Chitranshi2025,
  author = {Chitranshi, Nitin and Basavarajappa, Devaraj and Palanivel, Viswanthram and Parrilla, Gabriella E and Gupta, Veer and Paulo, Joao A and Salkar, Akanksha and Mirzaei, Mehdi and Koronyo-Hamaoui, Maya and Krezel, Wojciech and Graham, Stuart L and Gupta, Vivek K},
  title = {Retinoid X receptor alpha overexpression protects retinal ganglion cells and modulates inflammatory response in experimental glaucoma},
  journal = {Molecular Therapy},
  year = {2025},
  doi = {10.1016/j.ymthe.2025.08.034}
}
Kostenlos starten →